pentoxifylline

Generic: pentoxifylline

Labeler: ani pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pentoxifylline
Generic Name pentoxifylline
Labeler ani pharmaceuticals, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

pentoxifylline 400 mg/1

Manufacturer
ANI Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 70954-668
Product ID 70954-668_9732cf08-dad4-42a4-a10e-0284848724d7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074878
Listing Expiration 2026-12-31
Marketing Start 2024-01-15

Pharmacologic Class

Established (EPC)
blood viscosity reducer [epc]
Physiologic Effect
hematologic activity alteration [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70954668
Hyphenated Format 70954-668

Supplemental Identifiers

RxCUI
312301
UPC
0370954668107
UNII
SD6QCT3TSU
NUI
N0000175895 N0000009065

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pentoxifylline (source: ndc)
Generic Name pentoxifylline (source: ndc)
Application Number ANDA074878 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-10)
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-20)
source: ndc

Packages (2)

Ingredients (1)

pentoxifylline (400 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9732cf08-dad4-42a4-a10e-0284848724d7", "openfda": {"nui": ["N0000175895", "N0000009065"], "upc": ["0370954668107"], "unii": ["SD6QCT3TSU"], "rxcui": ["312301"], "spl_set_id": ["9ca79c97-e4e5-4297-85eb-7a9b3d8083b5"], "pharm_class_pe": ["Hematologic Activity Alteration [PE]"], "pharm_class_epc": ["Blood Viscosity Reducer [EPC]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-10)", "package_ndc": "70954-668-10", "marketing_start_date": "20240115"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-20)", "package_ndc": "70954-668-20", "marketing_start_date": "20240115"}], "brand_name": "Pentoxifylline", "product_id": "70954-668_9732cf08-dad4-42a4-a10e-0284848724d7", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Blood Viscosity Reducer [EPC]", "Hematologic Activity Alteration [PE]"], "product_ndc": "70954-668", "generic_name": "Pentoxifylline", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pentoxifylline", "active_ingredients": [{"name": "PENTOXIFYLLINE", "strength": "400 mg/1"}], "application_number": "ANDA074878", "marketing_category": "ANDA", "marketing_start_date": "20240115", "listing_expiration_date": "20261231"}